Jump to:
Amy Chappel is an associate in Ropes & Gray’s mergers & acquisitions group. She advises public and private companies and investors on domestic and cross-border transactions, including mergers, stock and asset acquisitions and tender offers. Amy also advises clients on strategic matters, securities laws, corporate governance and other general corporate matters.
Experience
M&A
- Represented AbbVie in its acquisition of Capstan Therapeutics, a cell therapy developer, for up to $2.1 billion.
- Represented Cardinal Health in its $1.1 billion acquisition of Specialty Networks, an integrated platform focused on independent physician practices in urology, gastroenterology and rheumatology, as well as life sciences organizations.
- Represented Novo Nordisk (Denmark) in its acquisition of Akero Therapeutics, a clinical stage company focused on metabolic diseases, for $5.2 billion.
- Represented Qorvo, Inc. in the sale of its United Silicon Carbide subsidiary and the silicon carbide junction field-effect transistor (SiC JFET) technology business to sensing technology firm ON Semiconductor.
- Represented EMCOR Group in connection with its $865 million acquisition of Miller Electric Company, a leading electrical contractor serving high growth areas across the southeastern United States.
- Represented Sigilon Therapeutics, Inc. in its acquisition by Eli Lilly and Company.
- Represented a leading medical technology company in multiple transactions.
- Represented StrideBio, Inc. in multiple asset divestitures.
- Represented Cambrex Corporation, a leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients, in its acquisition of Snapdragon Chemistry, Inc.
- Represented Radius Health, Inc. in its acquisition by Gurnet Point and Patient Square.
- Represented Medtronic plc in its acquisition of Affera, Inc., a cardiac ablation solutions company.
Corporate Governance and Shareholder Activism
- Represents Castanea Partners LLC on an ongoing basis with respect to corporate governance and general corporate matters relating to its investment in Jeni's Splendid Ice Creams, LLC, a retailer and wholesaler of branded artisanal ice creams.
- Represented Radius Health, Inc. in a proxy contest with an activist investor.
- Represented a pharmaceutical company in a proxy contest with an activist investor.